AC Immune (ACIU) EBIT Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | 12.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.35% |
| Dec 31, 2025 | 15.26% |
| Sep 30, 2025 | -340.88% |
| Jun 30, 2025 | -1.04% |
| Mar 31, 2025 | 6.29% |
| Dec 31, 2024 | -432.39% |
| Sep 30, 2024 | 147.92% |
| Jun 30, 2024 | -22.26% |
| Mar 31, 2024 | -21.03% |
| Dec 31, 2023 | 79.43% |
| Sep 30, 2023 | -25.61% |
| Jun 30, 2023 | 8.06% |
| Mar 31, 2023 | 6.83% |
| Dec 31, 2022 | 21.47% |
| Sep 30, 2022 | 36.90% |
| Jun 30, 2022 | -0.61% |
| Mar 31, 2022 | -6.86% |
| Dec 31, 2021 | -14.77% |
| Sep 30, 2021 | -8.13% |
| Jun 30, 2021 | -25.89% |
| Mar 31, 2021 | -152.75% |
| Dec 31, 2020 | -13.21% |
| Sep 30, 2020 | -211.97% |
| Jun 30, 2020 | -10.49% |
| Mar 31, 2020 | -112.50% |
| Dec 31, 2019 | -30.64% |
| Sep 30, 2019 | 247.49% |
| Jun 30, 2019 | -25.35% |
| Mar 31, 2019 | 605.95% |
| Dec 31, 2018 | -219.52% |
| Sep 30, 2018 | 29.10% |
| Jun 30, 2018 | -8.25% |
| Mar 31, 2018 | -53.00% |
| Dec 31, 2017 | -12.12% |
| Sep 30, 2017 | -110.75% |
| Mar 31, 2017 | -33.97% |
| Dec 31, 2016 | 317.51% |
| Sep 30, 2016 | -141.27% |